Canyon Labs acquires iuvo BioScience’s lab services and consulting, strengthening ophthalmic capabilities
Canyon Labs, a global leader in analytical and packaging lab testing for medical devices and pharmaceuticals, has acquired iuvo BioScience’s laboratory services and scientific consulting divisions, according to a press release.
This strategic acquisition enhances both companies’ market positions, enabling Canyon Labs to offer comprehensive end-to-end solutions in pharmaceutical and medical device development. It also strengthens iuvo BioScience’s focus on ophthalmic clinical research. The transition will integrate iuvo’s laboratory and consulting staff into Canyon Labs, while iuvo BioScience maintains its clinical research team and leadership.
“This transaction marks a defining moment for iuvo,” said Ben Burton, President and CEO of iuvo BioScience in the release. “This strategic decision reinforces our fundamental mission of accelerating patient access to breakthrough vision care treatments. By sharpening our focus on our ophthalmic clinical contract research business, we’re strengthening our ability to provide the high touch, science-driven solutions our customers and partners have come to expect from iuvo.”
Read the full press release here.
Related Content
